Analgesic ineffectiveness of lacosamide after spinal nerve ligation and its sodium channel activity in injured neurons
- 11 December 2012
- journal article
- Published by Wiley in European journal of pain
- Vol. 17 (6) , 881-892
Abstract
Background Lacosamide is a novel anti‐epileptic drug that enhances the slow‐ and not fast‐inactivating state of voltage‐gated sodium channels. Lacosamide has demonstrated analgesic efficacy in several animal studies but preclinical studies on neuropathic pain models are rare, and recent clinical trials showed no superior analgesic effects. Methods Here, we examine whether an acute or chronic administration of lacosamide (3–60 mg/kg, i.p.) attenuates pain behaviour induced by spinal nerve ligation (SNL). To validate the inhibitory efficacy of lacosamide on voltage‐gated sodium channels, sodium currents in naïve and SNL‐injured dorsal root ganglion (DRG) neurons were recorded using whole‐cell patch clamping. Results Lacosamide only marginally attenuated thermal hyperalgesia, but not tactile allodynia when applied once 7 or 14 days after SNL and showed no analgesic effect when applied daily for 19 days. In naïve neurons, 100 μmol/L lacosamide inhibited sodium channel currents by 58% and enhanced the slow inactivation (87% for lacosamide vs. 47% for control). In contrast, lacosamide inhibited sodium currents in injured DRG neurons by only 15%, while the effects on slow inactivation were diminished. Isolated currents from the NaV1.8 channel subtype were only marginally changed by lacosamide. Conclusion The reduced effectiveness of lacosamide on voltage‐gated sodium channel currents in injured DRG neurons may contribute to the reduced analgesic effect observed for the SNL model.Keywords
This publication has 59 references indexed in Scilit:
- Prevention of posttraumatic axon sprouting by blocking collapsin response mediator protein 2-mediated neurite outgrowth and tubulin polymerizationNeuroscience, 2012
- Isozyme-specific Effects of Protein Kinase C in Pain ModulationAnesthesiology, 2011
- Merging Structural Motifs of Functionalized Amino Acids and α-Aminoamides Results in Novel Anticonvulsant Compounds with Significant Effects on Slow and Fast Inactivation of Voltage-Gated Sodium Channels and in the Treatment of Neuropathic PainACS Chemical Neuroscience, 2011
- Development and Characterization of Novel Derivatives of the Antiepileptic Drug Lacosamide That Exhibit Far Greater Enhancement in Slow Inactivation of Voltage-Gated Sodium ChannelsACS Chemical Neuroscience, 2010
- In Silico Docking and Electrophysiological Characterization of Lacosamide Binding Sites on Collapsin Response Mediator Protein-2 Identifies a Pocket Important in Modulating Sodium Channel Slow InactivationJournal of Biological Chemistry, 2010
- Efficacy and Safety of Lacosamide in Diabetic Neuropathic PainThe Clinical Journal of Pain, 2009
- Increased Peripheral Nerve Excitability and Local Nav1.8 RNA Up-Regulation in Painful NeuropathyMolecular Pain, 2009
- Differing Alterations of Sodium Currents in Small Dorsal Root Ganglion Neurons after Ganglion Compression and Peripheral Nerve InjuryMolecular Pain, 2008
- A-803467, a potent and selective Na v 1.8 sodium channel blocker, attenuates neuropathic and inflammatory pain in the ratProceedings of the National Academy of Sciences, 2007
- A single sodium channel mutation produces hyper- or hypoexcitability in different types of neuronsProceedings of the National Academy of Sciences, 2006